Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Post by Charly50on Mar 18, 2021 3:56am
275 Views
Post# 32823824

Press conference , are uncomfortable questions allowed?

Press conference , are uncomfortable questions allowed?
It's not about trading 5% back and forth.
Even the old news is good enough to make the price rise !! The question is:
Why that hasn't happened yet.
* It's about the questions who manipulated the course for weeks?
(I firmly believe that the price has been clipped back down to 1.20 in order to carry out a corporate action)
* Why was the course stopped / suspended? (on the message from BIG PHARMA) "Stop, stop, we are not ready yet !!"
* Where would the course be today?
I think the piano is pretty out of tune and
Philipp should answer the question tonight how he will hit the right notes again in the future.
One should not mess with the shareholders and deal fairly with them, because they are the largest investors.
I think some of us are pretty pissed off and toyed with the idea of throwing our blocks of shares at Philip's feet.
One should not only behave in a friendly manner towards one investor, but towards all shareholders.
Philipp should know that we are sitting at a tuned piano.
Whats your opinion?
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse